Literature DB >> 15249698

Hypothyroidism as a risk factor for cardiovascular disease.

Bernadette Biondi1, Irwin Klein.   

Abstract

The cardiovascular risk in patients with hypothyroidism is related to an increased risk of functional cardiovascular abnormalities and to an increased risk of atherosclerosis. The pattern of cardiovascular abnormalities is similar in subclinical and overt hypothyroidism, suggesting that a lesser degree of thyroid hormone deficiency may also affect the cardiovascular system. Hypothyroid patients, even those with subclinical hypothyroidism, have impaired endothelial function, normal/depressed systolic function, left ventricular diastolic dysfunction at rest, and systolic and diastolic dysfunction on effort, which may result in poor physical exercise capacity. There is also a tendency to increase diastolic blood pressure as a result of increased systemic vascular resistance. All these abnormalities regress with L-T4 replacement therapy. An increased risk for atherosclerosis is supported by autopsy and epidemiological studies in patients with thyroid hormone deficiency. The "traditional" risk factors are hypertension in conjunction with an atherogenic lipid profile; the latter is more often observed in patients with TSH >10 mU/L. More recently, C-reactive protein, homocysteine, increased arterial stiffness, endothelial dysfunction, and altered coagulation parameters have been recognized as risk factors for atherosclerosis in patients with thyroid hormone deficiency. This constellation of reversible cardiovascular abnormalities in patient with TSH levels <10 mU/L indicate that the benefits of treatment of mild thyroid failure with appropriate doses of L-thyroxine outweigh the risk. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15249698     DOI: 10.1385/ENDO:24:1:001

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  152 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism.

Authors:  E Nyström; K Caidahl; G Fager; C Wikkelsö; P A Lundberg; G Lindstedt
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

3.  Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension.

Authors:  D H Streeten; G H Anderson; T Howland; R Chiang; H Smulyan
Journal:  Hypertension       Date:  1988-01       Impact factor: 10.190

4.  Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.

Authors:  M J Diekman; N M van der Put; H J Blom; J G Tijssen; W M Wiersinga
Journal:  Clin Endocrinol (Oxf)       Date:  2001-02       Impact factor: 3.478

5.  Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

Authors:  K S Woo; P Chook; Y I Lolin; A S Cheung; L T Chan; Y Y Sun; J E Sanderson; C Metreweli; D S Celermajer
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

6.  Acute effects of thyroid hormone on vascular smooth muscle.

Authors:  K Ojamaa; J D Klemperer; I Klein
Journal:  Thyroid       Date:  1996-10       Impact factor: 6.568

7.  Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth.

Authors:  J D Barth; H Jansen; D Kromhout; J H Reiber; J C Birkenhager; A C Arntzenius
Journal:  Atherosclerosis       Date:  1987-11       Impact factor: 5.162

8.  Measurement of cardiac muscle relaxation in hypothyroidism.

Authors:  J J Manns; A M Shepherd; J Crooks; D G Adamson
Journal:  Br Med J       Date:  1976-06-05

9.  Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.

Authors:  F Pazos; J J Alvarez; J Rubiés-Prat; C Varela; M A Lasunción
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

10.  Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism.

Authors:  E C Ridgway; D S Cooper; H Walker; D Rodbard; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

View more
  82 in total

1.  Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term.

Authors:  Z Beyhan; K Ertürk; G Uçkaya; E Bolu; H Yaman; M Kutlu
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

2.  [Thyroid diseases and hypertension].

Authors:  C Spitzweg; M Reincke
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

3.  Prevalence and clinical characteristics of hypothyroidism in a population undergoing maintenance hemodialysis.

Authors:  Klara Paudel
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  Hypothyroid cardiomyopathy in a patient post-doxorubicin chemotherapy.

Authors:  Adam Jeffrey Silver; Hena N Patel; Tochi Okwuosa
Journal:  BMJ Case Rep       Date:  2016-04-06

5.  An integrative pipeline for multi-modal discovery of disease relationships.

Authors:  Benjamin S Glicksberg; Li Li; Wei-Yi Cheng; Khader Shameer; Jörg Hakenberg; Rafael Castellanos; Meng Ma; Lisong Shi; Hardik Shah; Joel T Dudley; Rong Chen
Journal:  Pac Symp Biocomput       Date:  2015

6.  Effect of L-thyroxine treatment versus a placebo on serum lipid levels in patients with sub-clinical hypothyroidism.

Authors:  Xue Li; Zhaowei Meng; Qiang Jia; Xiaojun Ren
Journal:  Biomed Rep       Date:  2016-08-25

7.  Physical performance in newly diagnosed hypothyroidism: a pilot study.

Authors:  D Gallo; E Piantanida; G Veronesi; A Lai; L Sassi; V Lombardi; E Masiello; P Premoli; E Bianconi; C Cusini; S Rosetti; M L Tanda; A Toniolo; M Ferrario; L Bartalena
Journal:  J Endocrinol Invest       Date:  2017-04-22       Impact factor: 4.256

8.  Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study.

Authors:  Alessandro P Delitala; Maristella Steri; Maria Grazia Pilia; Mariano Dei; Sandra Lai; Giuseppe Delitala; David Schlessinger; Francesco Cucca
Journal:  Maturitas       Date:  2016-07-14       Impact factor: 4.342

9.  No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque.

Authors:  A P Delitala; F Filigheddu; M Orrù; M AlGhatrif; M Steri; M G Pilia; A Scuteri; M Lobina; M G Piras; G Delitala; E G Lakatta; D Schlessinger; F Cucca
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-10-21       Impact factor: 4.222

10.  Endothelial function is not changed during short-term withdrawal of thyroxine in patients with differentiated thyroid cancer and low cardiovascular risk.

Authors:  Hyuk-Jae Chang; Kyung Won Kim; Sung Hee Choi; Soo Lim; Kyoung Un Park; Do Joon Park; Dong Joo Choi; Hak C Jang; Bo Youn Cho; Young Joo Park
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.